Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
about
Oxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and TherapiesGenetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophyCharacterization of the Prokaryotic Sodium Channel NavSp Pore with a Microfluidic Bilayer PlatformP2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophyCalcium channel blockers and risk of breast cancer: a meta-analysis of 17 observational studiesElectrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy.Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cellsDrug Discovery of Therapies for Duchenne Muscular Dystrophy.Characterization of a multiprotein complex involved in excitation-transcription coupling of skeletal muscle.Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging.NOX2 Inhibition Impairs Early Muscle Gene Expression Induced by a Single Exercise Bout.Improvement of skeletal muscle performance in ageing by the metabolic modulator TrimetazidineAge-dependent changes in diastolic Ca(2+) and Na(+) concentrations in dystrophic cardiomyopathy: Role of Ca(2+) entry and IP3.Dysregulation of Intracellular Ca2+ in Dystrophic Cortical and Hippocampal Neurons.Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
P2860
Q26769962-F811E626-C833-4AF1-A4FF-D20023EF4C99Q28085320-5C542BA0-2CC0-4FAB-AC41-C60A24D031C3Q28546298-8DCD92CD-277F-4DD3-B13C-3BA832EBCBD0Q28550201-B586F715-E1DF-4CA3-A334-D1E11B2B0C2EQ34128263-0C632D0F-D0A1-47EB-BD85-1211882F2A77Q35054988-84F3994D-DA2C-4D39-B877-56B14009CED0Q35236912-0F2E8CBF-A838-414B-85EB-42B3E4E74297Q35612938-301697A6-4CD2-434B-B4BF-6F96DDD8B682Q38480698-4D66B940-844C-4A16-8229-0EAB510F1EBCQ38778936-6C891A60-FE09-4385-A377-AB1CB3EE22BDQ39459441-062CA46E-C960-4726-BF76-11415061487FQ42201999-93ED50A9-AE59-46BB-9155-9A074C079929Q42793119-1D7424C2-2F87-4080-9DBB-72B951F765E4Q43078220-C4603809-8E19-482E-BB08-A4151B5505BFQ44147291-CD2462C5-5902-4AF6-BBC3-0212C048DE03Q54116477-83CC1B21-93CD-47D3-9160-B3207FF64AE7
P2860
Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@ast
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@en
type
label
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@ast
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@en
prefLabel
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@ast
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@en
P2093
P2860
P1433
P1476
Nifedipine treatment reduces r ...... nction in dystrophic mdx mice.
@en
P2093
Denisse Valladares
Enrique Jaimovich
Jose R López
Mariana Casas
Paul D Allen
P2860
P304
P356
10.1371/JOURNAL.PONE.0081222
P407
P577
2013-12-09T00:00:00Z